Evaluation of Triumeq as a treatment for amyotrophic lateral sclerosis: The Lighthouse 2 UK Study

Al-Chalabi, Ammar (Primary Investigator)
Carter, Ben (Co-Investigator)
Kelly, Joanna (Co-Investigator)
academic, affiliated (Co-Investigator)

Project: Research

Acronym	The Lighthou
Status	Active
Effective start/end date	1/08/2021 → 31/07/2026

Collaborative partners

King's College London (lead)
University of Sheffield
KCH King's College Hospital NHS Foundation Trust
University College London

Funding

NIHR National Institute For Health & Care Research: £2,385,607.15